Anti-VEGF THERAPY:
Pazopanib and anti-VEGF therapy
6
Advances in MRI assessment of gliomas and response to anti-VEGF therapy.
10
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
6
Role of Diabetic Retinopathy Stage in the Outcome of Anti-VEGF Therapy in Macular Edema
5
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
11
Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy
5
Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
8
Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place Of Intravitreal Anti-VEGF Therapy
9
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration
7
Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
8
Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion
9
Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy
12
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
12
An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy
6
Tumor refractoriness to anti-VEGF therapy
10
Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration
8
Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer
7
Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis
11
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study
10
Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy
10